Calgary, Alberta--(Newsfile Corp. - April 19, 2024) - FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company"), to be renamed Consolidated Aerospace Finance Corporation ("CAFC") pursuant to the Name Change hereinafter described, and Great Slave Helicopters 2018 Ltd. ("GS Heli") are pleased to announce that further to the news release dated March 11, 2024, the parties, along with 15915074 Canada Inc. ("Subco"), a wholly owned subsidiary of FluroTech, have entered into a definitive agreement dated April 19, 2024 (the "Definitive Agreement") pursuant to the proposed acquisition of GS Heli by FluroTech (the "Transaction"). It is intended that the Transaction will constitute a "Change of Business" of FluroTech, as such term is defined in Policy 5.2 ("Policy 5.2") of the TSX Venture Exchange (the "TSXV"). Additionally, it is intended that the Transaction will constitute a "Reactivation" under the policies of the TSXV and that upon completion of the Transaction (the "Closing") and satisfaction of all conditions of the TSXV, FluroTech as it exists upon completion of the Transaction (the "Resulting Issuer") will have its listing transferred from the NEX board of the TSXV ("NEX") to the TSXV. The Transaction is expected to be completed in Q2 2024.

Calgary, Alberta--(Newsfile Corp. - March 11, 2024) - FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company") and Great Slave Helicopters 2018 Ltd. ("GS Heli") are pleased to announce that further to the news release dated December 21, 2023, the parties have entered into an updated non-binding letter of intent (the "Letter of Intent") which provides for an updated acquisition price and changes to the proposed board of directors. Pursuant to the Letter of Intent, the Company will acquire all the issued and outstanding shares of GS Heli (the "GS Heli Shares") pursuant to a share purchase, business combination, plan of arrangement or similar structure (the "Transaction"). It is intended that the Transaction will constitute a "Change of Business" for the Company, as such term is defined in Policy 5.2 ("Policy 5.2") of the TSX Venture Exchange (the "TSXV"). Additionally, it is intended that the Transaction will constitute the Company's "Reactivation" under the policies of the TSXV and that upon completion of the Transaction (the "Closing") and satisfaction of all conditions of the TSXV, the Company as it exists upon completion of the Transaction (the "Resulting Issuer") will have its listing transferred from the NEX board of the TSXV ("NEX") to the TSXV.

Toronto, Ontario--(Newsfile Corp. - December 21, 2023) - FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company") and Great Slave Helicopters 2018 Ltd. ("GS Heli") are pleased to announce that they have entered into a non-binding letter of intent in connection with an assignment agreement dated December 21, 2023 (the "Letter of Intent"), pursuant to which the Company and GS Heli intend to complete a business combination or other similarly structured transaction which will constitute a reverse take-over of the Company by GS Heli (the "Transaction"). In connection with the Transaction, the Company intends to acquire all of the issued and outstanding securities of GS Heli (the "GS Heli Shares"). It is intended that the Transaction will constitute a "Reverse Take-Over" for the Company, as such term is defined in Policy 5.2 ("Policy 5.2") of the Corporate Finance Manual of the TSX Venture Exchange (the "TSXV"). Additionally, it is intended that the Transaction will constitute the Company's "reactivation" under the policies of the TSXV and that upon completion of the Transaction (the "Closing") and satisfaction of all conditions of the TSXV, the Company as it exists upon completion of the Transaction (the "Resulting Issuer") will have its listing transferred from the NEX board of the TSXV ("NEX") to the TSXV.

VANCOUVER, BC, Dec. 21, 2023 /CNW/ - The following issues have been halted by CIRO

Calgary, Alberta--(Newsfile Corp. - November 6, 2023) - Danny Dalla-Longa announced today that on November 3, 2023 he acquired, directly or indirectly, beneficial ownership, control or direction over 28,624,108 common shares (the "Purchased Shares") of FluroTech Ltd. (the "Corporation"). Mr. Dalla-Longa acquired the Purchased Shares pursuant to a private share purchase transaction between Mr. Dalla-Longa and an existing shareholder of the Corporation in connection with the repayment of debt owed to Mr. Dalla-Longa in the aggregate amount of $225,000, representing a price of $0.00786051 per Purchased Share (the "Share Acquisition"). All of the Purchased Shares were acquired through Dalco Capital Corp., an entity wholly-owned by Mr. Dalla-Longa. The Purchased Shares represent 23.72% of the current number of issued and outstanding common shares of the Corporation. Mr. Dalla-Longa now beneficially owns or controls, directly or indirectly, an aggregate of 29,543,208 common shares of the Corporation, representing 24.48% of the Corporation's issued and outstanding common shares.

TORONTO, Oct. 27, 2023 /CNW/ - Trading resumes in:

Calgary, Alberta--(Newsfile Corp. - October 27, 2023) - FluroTech Ltd. (TSXV: TEST) (OTC Pink: FLURF) ("FluroTech" or the "Company") announces that effective October 30, 2023 the Company's listing on the TSX Venture Exchange (the "TSXV") will be transferred to the NEX Board of the TSXV (the "NEX"). The listing transfer is being made as a result of FluroTech not meeting the requirements of a Tier 2 company in accordance with TSXV Policy 2.5 - Continued Listing Requirements and Inter-Tier Movement.

VANCOUVER, BC, Oct. 26, 2023 /CNW/ -

Calgary, Alberta--(Newsfile Corp. - October 6, 2023) - FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) ("FluroTech" or the "Company") announces that the previously announced letter of intent, as amended, between FluroTech and Renewable Geo Resources Ltd. ("RGRL") dated April 14, 2023, in respect of the proposed business combination between FluroTech and RGRL (the "Proposed Transaction") as further described in the press release dated April 18, 2023, has been terminated in accordance with its terms.

Calgary, Alberta--(Newsfile Corp. - April 18, 2023) - FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) ("FluroTech" or the "Company") is pleased to announce that it has entered into a non-binding letter of intent ("LOI") dated April 14, 2023 to complete a business combination (the "Transaction") with Renewable Geo Resources Ltd. ("RGRL").

VANCOUVER, BC, April 17, 2023 /CNW/ - The following issues have been halted by IIROC:

FluroTech Ltd. (“FluroTech” or the “Company”) (TSXV: TEST) announces that it has entered into a Share Purchase Agreement (“Agreement”) to sell all of the shares of FluroTest Diagnostic Systems Ltd., a wholly-owned subsidiary of the Company, to an...

FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”) announces that it has decided to exit the pandemic and emerging disease industry immediately and halt any further expenditures on development of its Pandemic and Emerging...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (the “Company” or “FluroTech”), announces that it has decided to pause any further expenditures on development of its Pandemic and Emerging Disease Defense Platform (“PEDDP”), initially targeting COVID-19,...

FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a developer of diagnostics technology in high output rapid antigen testing for the detection of SARS-CoV-2 and other...

FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a developer of diagnostics technology in high output rapid antigen testing for the detection of SARS-CoV-2 and other...

FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a diagnostics technology leader in high output rapid antigen testing for the detection of SARS-CoV-2 and other...

FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a diagnostics technology leader in high output rapid antigen testing for the detection of SARS-CoV-2 and other...

FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a diagnostics technology leader in high output rapid antigen testing for the detection of SARS-CoV-2 and other...

New CMO Preps Aggressive SARS-CoV-2 Global Testing and Education Agenda as Company Confirms Variant Detection Capabilities in High-Volume Testing System

New CMO Preps Aggressive SARS-CoV-2 Global Testing and Education Agenda as Company Confirms Variant Detection Capabilities in High-Volume Testing System

VANCOUVER, BC, May 20, 2021 /CNW/ - Trading resumes in:

FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a diagnostics technology leader in high output rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, and its wholly owned subsidiary FluroTest...

VANCOUVER, BC, May 20, 2021 /CNW/ - The following issues have been halted by IIROC:

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) ("FluroTech" or the "Company"), a leading developer of spectroscopy-based technology, is pleased to announce that further to its news releases dated April 12, 2021 and May 7, 2021, the Early Warrant...

CALGARY, AB and MONTRÉAL, May 13, 2021 /CNW/ - FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostics Systems ("FluroTest" or The Company), a diagnostics technology leader in high output rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announces it has signed a strategic Memorandum of Understanding dated May 6, 2021 ("MoU") with SNC-Lavalin (TSX: SNC) to support pre-deployment, commercialization and operations phases of FluroTest's high-volume COVID-19 rapid antigen test platform.

Clinical Trial Progresses Across Six Clinical Site Locations Throughout the US

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) ("FluroTech" or the "Company"), a leading developer of spectroscopy-based technology, is pleased to announce that, further to its news release dated April 12, 2021, it has received TSX Venture Exchange...

CALGARY, AB, May 4, 2021 /CNW/ - FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) and subsidiary FluroTest Diagnostics Systems ("FluroTest" or The Company), a first-mover in surge-scale rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, are pleased to announce based on the data collected to date that the FluroTest platform will be capable of detecting the primary variants of concern now spreading across North America and fueling serious outbreaks around the world.

CALGARY, AB and LOS ANGELES, CA, May 3, 2021 /CNW/ - FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) and subsidiary FluroTest Diagnostics Systems  ("FluroTest" or The Company), a first-mover in surge-scale rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announces it has signed a strategic  Memorandum of Understanding ("MOU") with Total Testing Solutions, LLC ("TTS"), one of North America's premier providers of health testing to the professional sports, entertainment, venue ticketing and travel industries.

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) ("FluroTech" or the "Company"), a leading developer of spectroscopy-based technology, is pleased to announce it has received conditional approval from the TSX Venture Exchange (the "Exchange") to commence...

Brings prior experience as US Representative to the World Health Organization Executive Board and expertise in health care delivery, health policy, international affairs and pandemic influenza planning to FluroTest team

FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) is pleased to announce that it has granted incentive stock options the Board of Directors to purchase 225,000 common shares of FluroTech at a price of $0.45 per share for a term of two years in accordance...

VANCOUVER, BC, March 15, 2021 /CNW/ - Trading resumes in:

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, and FluroTest Systems Ltd. (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the detection of...

VANCOUVER, BC, March 15, 2021 /CNW/ - The following issues have been halted by IIROC:

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with joint venture FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with joint venture partner FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with joint venture FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the detection of...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the detection of...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the detection of...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce that is has engaged Venture Liquidity Providers Inc. (“VLP”), subject to regulatory approval, to provide market-making services for the purpose of...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce that, FluroTest Ltd. (“FluroTest”) has retained San Diego-based nanoComposix, a leading life sciences nanotechnology company that specializes in R&D...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce that it has closed the second and final tranche of its previously announced non-brokered private placement (the Offering”). 15,644,844 Units were...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce it has retained PandiaDx LLC (“PandiaDX”) for regulatory guidance and services in preparation of its regulatory submissions to the U.S. Food and Drug...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is very pleased to announce that it has closed the first tranche of a non-brokered private placement previously announced on December 7, 2020 (the “Offering”). A...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is exploring strategic alternatives for its Cannabis and Hemp testing business. While the Company’s Completest® system has proven beneficial to companies operating with the...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce a non-brokered private placement of units (“Units”) for gross proceeds of up to $2,500,000 (the “Offering”), subject to TSX Venture Exchange (the...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that FluroTest Systems Ltd. (“FluroTest”) today released a white paper titled “The Evolving Role of Antigen Testing in the COVID-19 Pandemic...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that FluroTest Systems Ltd. (“FluroTest”) will launch its first product solution to provide universities, colleges, as well as primary and secondary...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that (“FluroTest”) will launch its first product solution aimed at solving the testing problems airlines and airport terminal operators face as they...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that (“FluroTest”) will launch its first product solution aimed at solving the testing problems facing the operators of large stadiums, arenas, and...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that (“FluroTest”) will launch its first product solution aimed at solving the testing problems facing the operators of large stadiums, arenas, and...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that has begun optimization of its SARS-CoV2 rapid detection test method with nanoComposix, a highly regarded life science nanotechnology company that...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce, its previously announced joint venture FluroTest Systems Ltd. (“FluroTest”) will launch its first product and solution offering through a strategic...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that FluroTest, LLC (the “LLC”), a company in which the Company has an equity interest and which is developing a proprietary Pandemic Defense Platform...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that FluroTest LLC (“FluroTest”), a company in which the Company has an equity interest, has filed patent applications with the United States Patent...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to provide an update to its press releases dated April 16 and 20, 2020 in respect of FluroTest LLC (“FluroTest”), formed through a strategic agreement with the...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), a technology company focused on becoming the standard in the analytical cannabis testing market, is pleased to announce it has entered into an non-exclusive US distribution agreement with US based Mabre...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), is pleased to provide an update on its business strategy as it relates to the development of a COVID-19 analytical testing device. The scope of FluroTech’s contribution along with its equity participation...

VANCOUVER, April 16, 2020 /CNW/ - Trading resumes in:

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) is pleased to announce that it has entered into a strategic Agreement in Principle with Alberta BioPhotonics Inc. (“ABP”) and Albany Medical College (“AMC”) to form FluroTest LLC (“FluroTest”). The...

VANCOUVER, April 9, 2020 /CNW/ - The following issues have been halted by IIROC:

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), a technology company focused on becoming the standard in the analytical Cannabis and Hemp testing market, is pleased to announce it has entered into an non-exclusive US distribution agreement with North...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), a technology company focused on becoming the standard in the analytical cannabis and hemp testing market, announces that it has agreed to release CaryLand LLC from the non-exclusive distribution agreement...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) announces that the TSX Venture Exchange (the “Exchange”) has accepted its Notice of Intention (the “Notice”) to make a normal course issuer bid (“NCIB”) to purchase outstanding common shares (“Shares”) of...

LOS ANGELES, CA / ACCESSWIRE / January 27, 2020 / MjLink.com Inc. a wholly owned subsidiary of Social Life Network, Inc. (OTCQB:WDLF), is pleased to announce FluroTech Ltd. (OTCQB:FLURF)(TSX:TEST), as a Featured Presenter at their MjMicro Virtual Investor Conference hosted by MjInvest on Wednesday, January 29th at 2:30pm ET.

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), a technology company focused on becoming the standard in the analytical cannabis and hemp testing market, is pleased to announce a distribution agreement with CaryLand, LLC based in Boulder, Colorado....

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”), a technology company focused on the analytical cannabis and hemp testing market, is pleased to announce that it was the successful winner of the People’s Choice Award,...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”), a technology company focused on the analytical cannabis and hemp testing market, is pleased to announce five unit sales which generated revenue of $116,548 in September,...

FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”), a technology company focused on the analytical cannabis and hemp testing market, is pleased to announce it has been selected as one of the top 15 up and coming startups of...

FluroTech Ltd.(TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”), a technology company focused on the analytical cannabis and hemp testing market, has been awarded a Research License from Health Canada. The license permits the Company to...

FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”), an aspiring leader in analytical cannabis and hemp testing technologies, is pleased to be one of the featured presenters at the upcoming MjMicro conference in Beverley...

FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), an aspiring leader in analytical cannabis and hemp testing technologies, announces that, in order to test the performance of its biotracker technology outside of the...

FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”), an aspiring leader in analytical cannabis and hemp testing technologies, is pleased to be exhibiting at the Grow Up Conference & Expo this Thursday to Saturday at the...

FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to provide an update on its ongoing hemp beta tests with hemp growers/extractors in the U.S. and Canada who are validating the Company’s CBDA testing protocol....

Seattle, Washington--(Newsfile Corp. - July 10, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article and CEO video interview discussing FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF).

FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to provide a technology update. The Company previously disclosed the pause of sales after the company detected a contamination of certain test kits due to...

FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce the appointment of Duane Sniezek as the full-time Director of Science and Technology. Duane will be hands-on in leading enhancements of the...

via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing how technology trends are reshaping the industry....

via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF). The...

FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce that a favorable Written Opinion (“WO”) has been received for Patent Cooperation Treaty (“PCT”) Patent Application No. CA2018/051387 (the “PCT...

FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) recognizes the burgeoning market for the CompleTestTM hemp and cannabis testing device with a notable industry opportunity brought about by the signing of the 2018 United...

via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF). The...

FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce material developments related to the Company’s proprietary biomarker technology for cannabis and hemp plant cultivation and THC and CBD extract oils....

FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce that it has retained the services of InvestorsHub (“iHub”), of London, England, to conduct a 90-day investor and market visibility program beginning...

via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF). The...

FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce that it has retained the services of CFN Media (“CFN”) of Los Angeles, California. CFN is a leading investor relations and communications advisory...

FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce that the CompleTest™ was selected as the best of show for new cannabis technology by High! Canada Magazine at the recent Vancouver LIFT Expo. “The...

FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce that both the desktop and portable CompleTest™ devices, along with the related heavy metal and THCa and CBDa scopes, have been evaluated by LabTest...

FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”), is pleased to announce that its common shares commenced trading today on the OTCQB® Venture Market (“OTCQB”), under the symbol "FLURF". Real-time quotes and market...

Calgary, Alberta--(Newsfile Corp. - November 21, 2018) -  FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), is pleased to announce it has submitted its letter of intention to submit saliva-based roadside drug screening equipment for approval evaluation in early 2019 to the Drugs and Driving Committee (“DDC”), a committee within the Canadian Society of Forensic Science. The role of the DDC is to act as an advisory body to the Department of Justice with respect to issues of drug impaired driving. The DDC makes vital recommendations for the selection of the devices the police forces may use for roadside impairment testing for ∆9-tetrahydrocannabinol (“THC”), methamphetamines and cocaine. FluroTech has designed a device to meet the requirements of the DDC and will actively work to ensure the product meets their current and future needs.

Calgary, Alberta--(Newsfile Corp. - November 5, 2018) -  FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), is pleased to announce two recently-filed patent applications to which the Company holds exclusive, irrevocable rights for use in the cannabis industry. The patents include an international patent application filed October 31, 2018 pursuant to the Patent Cooperation Treaty ("PCT"), and a national phase entry filing of the PCT application at the United States Patent and Trademark Office (the "USPTO") on November 2, 2018. The PCT application allows for protection of the intellectual property in 152 countries, while the application at the USPTO will accelerate substantive input from the USPTO. The patent applications protect features of FluroTech's instrument that provide signal stability in the face of thermal and other fluctuations in the light source. These advances are utilized in the CompleTestTM device and roadside testing device resulting in unparalleled levels of sensitivity, signal stability and accuracy for portable instruments. Applications on other advanced designs for future generations of the device to maintain the Company's technical lead are in progress.

Calgary, Alberta--(Newsfile Corp. - November 1, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company") is pleased to introduce Mr. Curtis Smith as Chief Financial Officer taking over responsibilities from Mr. Gary Jones, who has been appointed Vice President of Business Development.

Calgary, Alberta--(Newsfile Corp. - October 23, 2018) -  FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), a developer of a human saliva-based testing device designed to accurately measure concentrations of ∆9-tetrahydrocannabinol ("THC"), methamphetamines and cocaine, is pleased to report that it has achieved the proof of concept to specifically detect cocaine below the 50 ng/ml cut-off, as required for roadside testing by the Canadian Society of Forensic Science Drugs and Driving Committee ("DDC") for Drug Screening Equipment. The development team will continue to validate the cocaine test and prove concept for THC and methamphetamines prior to commercialization of the drug test kits. Once the drug test kits are complete, they can be modified for employee testing with the CompleTest™ devices that are currently in production.

Calgary, Alberta--(Newsfile Corp. - October 19, 2018) -  FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), developer of the CompleTest™ device for cannabis quality control, detection of the Company's biomarker and developer of a human saliva testing device that determines concentrations of ∆9-tetrahydrocannabinol ("THC"), methamphetamines and cocaine for use in roadside and work place impairment testing, applauds the efforts by the Government of Canada and others to increase public awareness of the dangers of driving while impaired by drugs and the acute problems of being under the influence of drugs in the workplace. Saliva based testing is the preferred method of impairment testing by insurance companies, workplace safety programs and the Government of Canada for roadside testing.

Calgary, Alberta--(Newsfile Corp. - September 25, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), is pleased to report that preliminary Good Manufacturing Practice ("GMP") validation testing, done by the Drug Development and Innovation Center at the University of Alberta, of the CompleTest™ cannabinoid assays for THCa and CBDa were recorded at less than 2% difference when compared to the industry quality control standard High Performance Liquid Chromatography ("HPLC") technology.

Calgary, Alberta--(Newsfile Corp. - September 18, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), is pleased to announce the appointment of Dr. Trevor MacMillan as Director of Scientific Research and Business Development. With prior industry experience at Aurora Cannabis Inc., Dr. MacMillan brings with him an impressive background in plant breeding, biotechnology regulatory environments and quality control. He will be an integral part of FluroTech's scientific and business development teams.

Calgary, Alberta--(Newsfile Corp. - September 14, 2018) - FluroTech Ltd. (TSXV: TEST) ("FluroTech" or the "Company") announces that, further to its prior press release on September 10, 2018, the Company has refiled its June 30, 2018 interim financial statements and amended Management's Discussion & Analysis for the same period. The material changes to the interim filings were as a result of a change in the comparative periods presented in the interim filings, to properly reflect the change in financial year end of the Company.

VANCOUVER, Sept. 10, 2018 /CNW/ - Trading resumes in:

Calgary, Alberta--(Newsfile Corp. - September 9, 2018) - FluroTech Ltd. (TSXV: TEST) ("FluroTech" or the "Company") announces that, further to the trading halt of its shares, pending announcement, this release clarifies the status of certain of its regulatory filings. Due to inadvertence resulting from a recent change in the financial year end of the Company, the Company failed to file financial statements and other related documents resulting in the Company being noted in default by the regulators. The Company is working proactively with the regulators to address all issues related to this matter as soon as practicable, and in any event no later than the end of September. The Company expects to file its June 30, 2018 interim financial statements and amended Management's Discussion & Analysis for the same period next week. Trading will be resumed in normal course upon dissemination of this news release. 

VANCOUVER, Sept. 6, 2018 /CNW/ - The following issues have been halted by IIROC:

Calgary, Alberta--(Newsfile Corp. - September 5, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), has successfully completed the development of the test kits for THCa and CBDa. When used with the Company's flagship quality control and potency optimization testing device, the CompleTest™, accurate, reliable and consistent THCa and CBDa testing results can be achieved onsite within 15 minutes with this user friendly solution.

Calgary, Alberta--(Newsfile Corp. - August 29, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), today announced results for its second quarter ended June 30, 2018.

Calgary, Alberta--(Newsfile Corp. - August 29, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), applauds the steps Canada is taking to address issues of impaired driving while under the influence of drugs. The Company believes it's important that law enforcement has adequate tools in place to help accurately and efficiently determine drug concentrations in saliva, such as THC, cocaine and methamphetamines, which can be used as an indicator of impairment.

TORONTO, Aug. 14, 2018 /CNW/ - Danny Dalla-Longa, Co-Founder and CEO, FluroTech Ltd. (TEST), joined Tim Babcock, Managing Director, Capital Formation, TMX Group, to open the market. FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech Ltd. commenced trading on TSX Venture Exchange on June 12, 2018.

Calgary, Alberta--(Newsfile Corp. - July 23, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), one of the leaders in cannabis quality control technology, has completed the test kits for cadmium, lead and mercury heavy metals. The heavy metal test kits, the heavy metal scope and the CompleTest™ device will allow users to achieve fast, accurate, and consistent testing results in-house on a cost effective basis. Results from each test are logged into our proprietary software and can be exported to external databases. Additionally, FluroTech's training application teaches users how to conduct the tests in hours and allows supervisors to monitor staff's progress and test results.

Calgary, Alberta--(Newsfile Corp. - July 19, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company") is pleased to announce that it has closed its previously announced purchase of the royalty from University Technologies International Limited Partnership ("UTI"). The Company has issued 333,334 FluroTech common shares, at a deemed price of $0.45 per share, to UTI in exchange for UTI selling its one percent royalty on net product sales of FluroTech back to the Company.

Calgary, Alberta--(Newsfile Corp. - July 18, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company"), is pleased to announce that through the collaboration of nanoscientists, botanists and biochemists, it has demonstrated the proof of principle to specifically label cannabis oil in a manner that will allow fast, on-site identification of legal products using the CompleTest™ technology, economically and without the need for technical training. The Company's research suggests that governments and licensed producers are looking for a reliable, accurate technology to improve on existing conventional seed to sale tracking to ensure cannabis supply chain security.

Vancouver, British Columbia--(Newsfile Corp. - July 17, 2018) - Dan Dalla-Longa, CEO & Director at FluroTech gives insight into the company's testing technology that is expected to disrupt the cannabis industry.

Vancouver, British Columbia--(Newsfile Corp. - July 17, 2018) - David Lahey, Founder & President of Predictive Success Corp. talks about their talent acquisition and human resources software.

Calgary, Alberta--(Newsfile Corp. - July 3, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company") is pleased to announce that it has finalized the engineering & design of its flagship product, CompleTest™, and engaged a third party manufacturer to produce the first commercial production run of the housing for the CompleTest™ Series 1 device.

Calgary, Alberta--(Newsfile Corp. - June 20, 2018) - FluroTech Ltd. (TSXV: TEST) ("FluroTech" or the "Company") is pleased to announce the hiring of Derek Clark as Executive Commercialization Consultant. Derek is responsible for driving the commercialization of the Company's first product line, CompleTest™, developing the go-to-market strategy and building out the commercial team at FluroTech. Derek will also advise the Executive Leadership Team at FluroTech on company strategy as the Company commercializes its technology for roadside testing, industrial testing and bio-marking over the next several quarters.

Calgary, Alberta--(Newsfile Corp. - June 18, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company") is pleased to announce that it has retained the services of Thesis Capital Inc. ("Thesis") of Toronto, ON a leading investor relations and capital markets advisory firm servicing Canadian small cap companies across the North American markets. Thesis will provide investor relations and communication services to FluroTech, subject to TSXV approval.

Calgary, Alberta--(Newsfile Corp. - June 13, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company") is pleased to announce that, pursuant to the terms of a royalty purchase agreement entered into with UTI Limited Partnership ("UTI"), the Company has agreed to issue 333,334 FluroTech common shares, at a deemed price of $0.45 per share, to UTI in exchange for UTI selling its one percent royalty on net product sales of FluroTech back to the Company.

Calgary, Alberta--(Newsfile Corp. - June 12, 2018) - FluroTech Ltd. (TSXV: TEST), ("FluroTech" or the "Company") is pleased to announce the initial trading of company shares under the symbol TEST on the TSX Venture Exchange.

VANCOUVER, June 11, 2018 /CNW/ - Trading resumes in:

Calgary, Alberta--(Newsfile Corp. - June 5, 2018) - Snow Eagle Resources Ltd. ("Snow Eagle") and CannaTest Photonics Ltd. ("CannaTest") (collectively the "Companies") have completed the qualifying transaction (the "Transaction") previously announced, on the terms set out in the definitive agreement dated January 8, 2018 by amalgamating and continuing as FluroTech Ltd. ("FluroTech" or "the Company"). The Transaction was unanimously approved by the shareholders of both Snow Eagle and CannaTest represented in person or by proxy at their respective shareholder meetings.

Test Company of San Francisco (NYSE:TEST) (TSX:TEST) (BSE:TEST) (LSE:TEST) issued their third quarter earnings statement today. Test Company reported diluted earnings per share of $0.11 in the third quarter of 2010, down by 1.1% from $1.01 in the third quarter of 2009, principally due to a $0.08 tax benefit recorded in 2009.